Bioorganic & Medicinal Chemistry Letters 16 (2006) 3869–3869
Corrigendum
Corrigendum to ‘‘Tricyclic azepine derivatives: Pyrimido[4,5-b]-1,4-benzoxazepines as a novel class of epidermal growth factor receptor kinase inhibitors’’ [Bioorg. Med. Chem. Lett. 16 (2006) 1643–1646] Leon Smith, II,a, Evgueni L. Piatnitski,a,* Alexander S. Kiselyov,a,à Xiaohu Ouyang,a Xiaoling Chen,a Sabina Burdzovic-Wizemann,a Yongjiang Xu,a Weitao Pan,a Xin Chen,a Ying Wang,b Robin L. Rosler,b Sheetal N. Patel,b Hui-Hsien Chiang,b Daniel L. Milligan,a John Columbus,a Wai C. Wong,a Jacqueline F. Doodyb and Yaron R. Hadarib b
a Department of Chemistry, ImClone Systems, 180 Varick Street, New York, NY 10014, USA Department of Protein Science, ImClone Systems, 180 Varick Street, New York, NY 10014, USA
Available online 18 May 2006
The names of Weitao Pan and Xin Chen were inadvertently omitted from the author line. The correct author line appears above.
DOI of original article: 10.1016/j.bmcl.2005.12.018. * Corresponding author. Tel.: +1 718 473 5557; e-mail:
[email protected] Present address: Bristol-Myers Squibb, PO Box 5400, Princeton, NJ 08543, USA. à Present address: Chemical Diversity, 1155 Sorrento Valley Road, Suite 5, San Diego, CA 92121, USA. 0960-894X/$ - see front matter Ó 2006 Elsevier Ltd. All rights reserved. doi:10.1016/j.bmcl.2006.04.058